rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Oxygenta Pharmaceutical Ltd - Outcome Of Board Meeting Under Regulation 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015.
Download announcement < Back
04 Mar 2024
Re-appointment of Mrs. Padmaja Surapureddy (DIN: 05358127) as Non-executive Independent Director of the Company
View all announcements for Oxygenta Pharmaceutical Ltd Source: BSE India